General
 |
|
28 january 2020 20:00:08 |
| Dipeptidyl peptidase-4 inhibitor anagliptin reduces fasting apolipoprotein B-48 levels in patients with type 2 diabetes: A randomized controlled trial (PLoS ONE) |
|
Tweet |
| 211 viewsCategory: Biology, Chemistry, General |
 Adult health burden and costs in California during 2013 associated with prior adverse childhood experiences (PLoS ONE)T helper cell-related changes in peripheral blood induced by progressive effort among soccer players (PLoS ONE) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
